Abstract
Systemic autoimmune myopathies (SAM) are a group of rare rheumatic diseases associated with high morbidity and disability. Recent studies have shown a high prevalence of hyperlipidemia in patients with SAM. While statins are commonly used lipid-lowering medications, the safety of statin use in patients with SAM is still unclear. The objective of this study was to evaluate the safety of statin use in patients with pre-existing SAM. We performed a single-center retrospective cohort study of adult patients with clinically diagnosed SAM between 2008-2018.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
